The latest evidence for possible HIV-1 curative strategies by Hanh Thi Pham, Thibault Mesplède

Get full text

Resistance against Integrase Strand Transfer Inhibitors and Relevance to HIV Persistence by Thibault Mesplède, Mark A. Wainberg

Get full text

Will LEDGIN molecules be able to play a role in a cure for HIV infection? by Thibault Mesplède, Mark A. Wainberg

Get full text

Is Resistance to Dolutegravir Possible When This Drug Is Used in First-Line Therapy? by Thibault Mesplède, Mark A. Wainberg

Get full text

The R263K resistance substitution decreases levels of integrated HIV DNA over time by Thibault Mesplède, Mark A. Wainberg

Get full text

Nonhuman Primates and Humanized Mice for Studies of HIV-1 Integrase Inhibitors: A Review by Said A. Hassounah, Thibault Mesplède, Mark A. Wainberg

Get full text

HIV drug resistance against strand transfer integrase inhibitors by Kaitlin Anstett, Bluma Brenner, Thibault Mesplede, Mark A. Wainberg

Get full text

Exploring an alternative explanation for the second phase of viral decay: Infection of short-lived cells in a drug-limited compartment during HAART. by Steven Sanche, Thibault Mesplède, Nancy L Sheehan, Jun Li, Fahima Nekka

Get full text

Pharmaceutical, clinical, and resistance information on doravirine, a novel non-nucleoside reverse transcriptase inhibitor for the treatment of HIV-1 infection by Hanh Thi Pham, Meng A Xiao, Miguel AV Principe, Alexander Wong, Thibault Mesplède

Get full text

Structural Studies of the HIV-1 Integrase Protein: Compound Screening and Characterization of a DNA-Binding Inhibitor. by Peter K Quashie, Ying-Shan Han, Said Hassounah, Thibault Mesplède, Mark A Wainberg

Get full text

Selection of the R263K and H51Y resistance substitutions for DTG causes diminished integration and explains the lack of clinically significant drug resistance to this compound by Thibault Mesplède, Jiaming Liang, Katlin Anstett, Nathan Osman, Hanh Thi Pham, Mark A. Wainberg

Get full text

Fitness Impaired Drug Resistant HIV-1 Is Not Compromised in Cell-to-Cell Transmission or Establishment of and Reactivation from Latency by Sophie M. Bastarache, Thibault Mesplède, Daniel A. Donahue, Richard D. Sloan, Mark A. Wainberg

Get full text

Erratum for Mesplède et al., “The R263K Dolutegravir Resistance-Associated Substitution Progressively Decreases HIV-1 Integration” by Thibault Mesplède, Jing Leng, Hanh Thi Pham, Jiaming Liang, Yudong Quan, Yingshan Han, Mark A. Wainberg

Get full text

Genotypic and Phenotypic Characterization of Replication-Competent HIV-2 Isolated from Controllers and Progressors by Cynthia Lungu, Ronald J. Overmars, Esmée Grundeken, Patrick H. M. Boers, Marchina E. van der Ende, Thibault Mesplède, Rob A. Gruters

Get full text

Selective resistance profiles emerging in patient-derived clinical isolates with cabotegravir, bictegravir, dolutegravir, and elvitegravir by Maureen Oliveira, Ruxandra-Ilinca Ibanescu, Kaitlin Anstett, Thibault Mésplède, Jean-Pierre Routy, Marjorie A. Robbins, Bluma G. Brenner, the Montreal Primary HIV (PHI) Cohort Study Group

Get full text

HIV-1 resistance against dolutegravir fluctuates rapidly alongside erratic treatment adherence: a case report by Jeroen J.A. van Kampen, Hanh Thi Pham, Sunbin Yoo, Ronald J. Overmars, Cynthia Lungu, Rizwan Mahmud, Carolina A.M. Schurink, Sander van Boheemen, Rob A. Gruters, Pieter L.A. Fraaij, David M. Burger, Jolanda J.C. Voermans, Casper Rokx, David A.M.C. van de Vijver, Thibault Mesplède

Get full text